ABBOTT LABORATORIES·4

Feb 27, 6:17 PM ET

MCCOY JOHN A. JR. 4

4 · ABBOTT LABORATORIES · Filed Feb 27, 2025

Insider Transaction Report

Form 4
Period: 2025-02-25
MCCOY JOHN A. JR.
VICE PRESIDENT AND CONTROLLER
Transactions
  • Award

    Common shares without par value

    2025-02-25+4,03822,719 total
  • Award

    Option (right to buy)

    2025-02-25+15,04015,040 total
    Exercise: $135.42From: 2026-02-25Exp: 2035-02-24Common Shares (15,040 underlying)
Holdings
  • Common shares without par value

    (indirect: By Trust)
    57
Footnotes (3)
  • [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
  • [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of February 25, 2025.
  • [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 5,013 on February 25, 2026, 5,013 on February 25, 2027, and 5,014 on February 25, 2028.

Documents

1 file
  • 4
    form4-02272025_110224.xmlPrimary